Paclitaxel-based versus docetaxel-based regimens in metastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials

By Qi Wei-Xiang   Shen Zan   Lin Feng   Sun Yuan-jue   Min Da-liu   Tang Li-Na   He Ai-Na   Yao Yang  

Current Medical Research and Opinion, Vol. 29, Iss. 2, 2013-02 ,pp. : 117-125

Informa Healthcare

Access to resources Recommend Favorite

A comparative analysis of risk management strategies in European Union and United States pharmaceutical regulation

By Davis Courtney   Abraham John  

Health, Risk & Society, Vol. 13, Iss. 5, 2011-08 ,pp. : 413-431

Routledge Ltd

Access to resources Recommend Favorite

Assessing the quality of life of patients in phases I and II anti-cancer drug trials: Interviews versus questionnaires by Cox K

By McKenna S.P.  

Social Science and Medicine, Vol. 58, Iss. 3, 2004-02 ,pp. : 659-660

Elsevier

Access to resources Recommend Favorite

Assessing the quality of life in phase I and II anti-cancer drug trials: interviews versus questionnaires

By Cox K.  

Social Science and Medicine, Vol. 58, Iss. 3, 2004-02 ,pp. : 661-661

Elsevier

Access to resources Recommend Favorite

Comparative effectiveness of fingolimod versus interferons or glatiramer acetate for relapse rates in multiple sclerosis: a retrospective US claims database analysis

By Bergvall Niklas   Makin Charles   Lahoz Raquel   Agashivala Neetu   Pradhan Ashish   Capkun Gorana   Petrilla Allison   Karkare Swapna U.   Balderston McGuiness Catherine   Korn Jonathan R.  

Current Medical Research and Opinion, Vol. 29, Iss. 12, 2013-12 ,pp. : 1647-1656

Informa Healthcare

Access to resources Recommend Favorite